Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Secukinumab

Brand: Cosentyx®
NICE TA: 
Indication: Palmoplantar psoriasis
Disease category: Skin
Commissioning responsibility: CCG
PbR excluded: Yes

Background

Secukinumab is recommended for the treatment of moderate to severe palmoplantar psoriasis that has not responded (refractory) to at least two standard systemic treatments and photochemotherapy, or when standard treatments cannot be used because of intolerance or contra-indications.

Recommendation

LMMG recommendation: Red
Click here to find the definitions for the colour classifications

Reason for decision:  Specialist medicine

Supporting documents:

LMMG New Medicine Recommendation - Secukinumab (655.5 KiB)

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Red

Red

Red

Red

Red

Red